Engineering Biology & Biomanufacturing

Engineering biology reaches into medicine, materials, food, chemicals and energy. The constraint is rarely the science. It is fermentation, scale-up and manufacturing capacity.

• British engineering biology companies manufacturing in Britain
• Shared scale-up capacity reducing the cost of the first plant
• Bio-based substitution in materials, food and chemicals

Comparable in function to Denmark's industrial biotechnology base or the US BioMADE model.

• Strong synthetic and engineering biology research base.
• Existing industrial biotechnology and fermentation know-how.
• Adjacent chemicals and process industry sites with usable infrastructure.

Current geographic hypothesis: Distributed. Core capability concentrates around Cambridge, Liverpool, Norwich and the East, with complementary strength in Edinburgh, Manchester and Teesside.. This is indicative geography — a record of where relevant capability is concentrated today, not a decision that this mission belongs to one place or that anything would be built there.

• Earlham Institute and the Norwich Research Park
• Cambridge engineering biology research
• Industrial biotechnology capability in the North West and Teesside

The types of organisation and individual already active in this capability. Listing a participant type is a description of the ecosystem, not membership, endorsement or a commitment by anyone named or implied.

• Engineering biology founders
• Process and chemical engineers
• Industrial partners
• Deep-tech and climate investors

• Synthetic biology
• Biomanufacturing and fermentation
• Bio-based materials
• Industrial biotechnology

• Earlham Institute
• University of Cambridge
• University of Edinburgh
• University of Manchester

• Fermentation and scale-up capacity
• Pilot plants
• Bioprocess and downstream processing
• Biofoundries

Listing infrastructure is not a proposal to build it. Physical intervention is only recommended where evidence demonstrates additionality.

1. Research→
2. Problem→
3. Prototype→
4. Company→
5. Capital→
6. Customer→
7. Scale→
8. Export

• British engineering biology companies manufacturing in Britain
• Shared scale-up capacity reducing the cost of the first plant
• Bio-based substitution in materials, food and chemicals

These are hypotheses to be tested, not forecasts, targets or guarantees. Each would need to pass the additionality test — would it happen anyway, or happen elsewhere in Britain? — before it counts as a reason to intervene. UKIZ makes no projections it cannot evidence.